- Home
- GPRK vs ABEO Comparison
GPRK vs ABEO Comparison
Compare GPRK & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- ABEO
- Stock Information
- Founded
- GPRK 2002
- ABEO 1974
- Country
- GPRK Colombia
- ABEO United States
- Employees
- GPRK N/A
- ABEO N/A
- Industry
- GPRK Oil & Gas Production
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- GPRK Energy
- ABEO Health Care
- Exchange
- GPRK Nasdaq
- ABEO Nasdaq
- Market Cap
- GPRK 335.7M
- ABEO 281.0M
- IPO Year
- GPRK N/A
- ABEO 1980
- Fundamental
- Price
- GPRK $6.82
- ABEO $5.23
- Analyst Decision
- GPRK Buy
- ABEO Strong Buy
- Analyst Count
- GPRK 1
- ABEO 6
- Target Price
- GPRK $11.00
- ABEO $18.17
- AVG Volume (30 Days)
- GPRK 1.5M
- ABEO 1.0M
- Earning Date
- GPRK 11-05-2025
- ABEO 11-13-2025
- Dividend Yield
- GPRK 8.25%
- ABEO N/A
- EPS Growth
- GPRK N/A
- ABEO N/A
- EPS
- GPRK 0.81
- ABEO 0.99
- Revenue
- GPRK $560,354,000.00
- ABEO $400,000.00
- Revenue This Year
- GPRK N/A
- ABEO N/A
- Revenue Next Year
- GPRK N/A
- ABEO $324.71
- P/E Ratio
- GPRK $8.46
- ABEO $5.34
- Revenue Growth
- GPRK N/A
- ABEO N/A
- 52 Week Low
- GPRK $5.66
- ABEO $3.93
- 52 Week High
- GPRK $11.72
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- GPRK 56.35
- ABEO 39.16
- Support Level
- GPRK $6.80
- ABEO $5.29
- Resistance Level
- GPRK $7.29
- ABEO $5.61
- Average True Range (ATR)
- GPRK 0.29
- ABEO 0.23
- MACD
- GPRK 0.08
- ABEO 0.02
- Stochastic Oscillator
- GPRK 71.43
- ABEO 3.89
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.